ZEB2 and ZEB1 expression in a spontaneous canine model of invasive micropapillary carcinoma of the mammary gland

被引:12
|
作者
Gamba, C. O. [1 ]
Campos, L. C. [1 ]
Negreiros-Lima, G. L. [2 ]
Maciel-Lima, K. [2 ]
Sousa, L. P. [2 ]
Estrela-Lima, A. [3 ]
Ferreira, E. [1 ]
Cassali, G. D. [1 ]
机构
[1] Univ Fed Minas Gerais, Dept Patol Geral, Inst Ciencia Biol, BR-31270901 Belo Horizonte, MG, Brazil
[2] Univ Fed Minas Gerais, Dept Anal Clin & Toxicol, Fac Farm, BR-31270901 Belo Horizonte, MG, Brazil
[3] Univ Fed Bahia, Escola Med Vet, Dept Patol & Clin, BR-40170110 Salvador, BA, Brazil
关键词
Canine; Mammary gland; Invasive micropapillary carcinoma; Immunohistochemistry; ZEB1; ZEB2; EPITHELIAL-MESENCHYMAL TRANSITION; TRANSCRIPTION FACTOR ZEB1; E-CADHERIN REPRESSORS; BREAST; SIP1; CANCER; TWIST; SNAIL; SLUG; DIAGNOSIS;
D O I
10.1016/j.rvsc.2014.09.016
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
ZEB1 and ZEB2 have been recently related to cancer prognosis. We investigated their expression and its association with clinicopathological parameters and overall survival in invasive micropapillary carcinoma (IMPC), which is a metastasising neoplasm of the canine mammary gland. Immunohistochemical evaluation showed nuclear and cytoplasmic staining for ZEB2 and nuclear staining for ZEB1. 'In situ' areas presented higher positivity for cytoplasmic ZEB2 than invasive areas of IMPC did (p = 0.03). ZEB1 positivity was associated with a low histological grade (p = 0.01). A shorter overall survival rate was observed in IMPCs that were positive for cytoplasmic ZEB2 (p = 0.04). Antibodies specificity in canine species was confirmed by western blot. Our results indicated that cytoplasmic ZEB2 appears to be an important factor in the early stages of malignancy and predicts a poor overall survival rate for IMPC in this canine mammary cancer model. ZEB1 downregulation appears to be associated with the dedifferentiation process of IMPC. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:554 / 559
页数:6
相关论文
共 50 条
  • [1] The investigation of transcriptional repression mediated by ZEB2 in canine invasive micropapillary carcinoma in mammary gland
    Gamba, Conrado de Oliveira
    Damasceno, Karine Araujo
    Ferreira, Izabel Cristina
    Rodrigues, Michele Angela
    Gomes, Dawidson Assis
    Alves, Mariana Resende
    Rocha, Rafael Malagoli
    Lima, Alessandra Estrela
    Ferreira, Enio
    Cassali, Geovanni Dantas
    PLOS ONE, 2019, 14 (01):
  • [2] ZEB1 and ZEB2 transcription factors are potential therapeutic targets of canine mammary cancer cells
    Xavier, Pedro L. P.
    Cordeiro, Yonara G.
    Rochetti, Arina L.
    Sangalli, Juliano R.
    Zuccari, Debora A. P. C.
    Silveira, Juliano C.
    Bressan, Fabiana F.
    Fukumasu, Heidge
    VETERINARY AND COMPARATIVE ONCOLOGY, 2018, 16 (04) : 596 - 605
  • [3] The investigation of transcriptional repression mediated by ZEB2 in canine invasive micropapillary carcinoma in mammary gland (vol 14, e0209497, 2019)
    Gamba, Conrado de Oliveira
    Damasceno, Karine Araujo
    Ferreira, Izabel Cristina
    Rodrigues, Michele Angela
    Gomes, Dawidson Assis
    Alves, Mariana Resende
    Rocha, Rafael Malagoli
    Lima, Alessandra Estrela
    Ferreira, Enio
    Cassali, Geovanni Dantas
    PLOS ONE, 2019, 14 (03):
  • [4] Expression of Zeb1 and Zeb2 indicates metastasis and unfavorable prognosis in osteosarcoma
    Zhang, Xueyu
    Lei, Xing
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (01): : 611 - 617
  • [5] Tumoral and stromal expression of Slug, ZEB1, and ZEB2 in brain metastasis
    Nagaishi, Masaya
    Nakata, Satoshi
    Ono, Yuko
    Hirata, Koji
    Tanaka, Yoshihiro
    Suzuki, Kensuke
    Yokoo, Hideaki
    Hyodo, Akio
    JOURNAL OF CLINICAL NEUROSCIENCE, 2017, 46 : 124 - 128
  • [6] Dualistic role of ZEB1 and ZEB2 in tumor progression
    Parfenyev, Sergey E.
    Daks, Alexandra A.
    Shuvalov, Oleg Y.
    Fedorova, Olga A.
    Pestov, Nikolay B.
    Korneenko, Tatyana V.
    Barlev, Nickolai A.
    BIOLOGY DIRECT, 2025, 20 (01)
  • [7] Suppression of SDC-1 expression by overexpression of ZEB1/ZEB2 in prostate cancer cells
    Contreras, H.
    Farfan, N.
    Orellana-Serradell, O.
    Chrzanowsky, D.
    Castellon, E.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S26 - S26
  • [8] The mesodermal and myogenic specification of hESCs depend on ZEB1 and are inhibited by ZEB2
    Ninfali, Chiara
    Siles, Laura
    Esteve-Codina, Anna
    Postigo, Antonio
    CELL REPORTS, 2023, 42 (10):
  • [9] LBX2-AS1 is activated by ZEB1 and promotes the development of esophageal squamous cell carcinoma by interacting with HNRNPC to enhance the stability of ZEB1 and ZEB2 mRNAs
    Zhang, Yanshan
    Chen, Weizuo
    Pan, Tingting
    Wang, Huijuan
    Zhang, Yinguo
    Li, Chao
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 511 (03) : 566 - 572
  • [10] Expression of miRNAs and ZEB1 and ZEB2 correlates with histopathological grade in papillary urothelial tumors of the urinary bladder
    Lee, Heejeong
    Jun, Sun-Young
    Lee, Youn-Soo
    Lee, Hee Jin
    Lee, Weon Sun
    Park, Chul Soo
    VIRCHOWS ARCHIV, 2014, 464 (02) : 213 - 220